Logo 202 Logo 202 (Methylphenidate hydrochloride extended-release 40 mg)
Pill imprint Logo 202 Logo 202 has been identified as Methylphenidate hydrochloride extended-release 40 mg.
Methylphenidate is used in the treatment of adhd; narcolepsy; fatigue; depression; obesity (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 40 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
More about methylphenidate
- Methylphenidate chewable tablets
- Methylphenidate controlled-release capsules
- Methylphenidate controlled-release tablets
- Methylphenidate extended-release capsules
- More (7) »
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.